Aerosolized active agent delivery

Details for Australian Patent Application No. 2006201914 (hide)

International Classifications

Event Publications

25 May 2006 Application Open to Public Inspection

Published as AU-B-2006201914

25 May 2006 Complete Application Filed

8 November 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

10 April 2008 Section 223 Application Received

Nektar Therapeutics An application to extend the time from 11 Mar 2007 to 11 Oct 2007 in which to pay a continuation fee has been filed . Address for service in Australia - Griffith Hack GPO Box 3125 Brisbane QLD 4001

29 May 2008 Section 223 Application Allowed

Nektar Therapeutics The time in which to pay a continuation fee has been extended to 11 Oct 2007. Address for service in Australia - Griffith Hack GPO Box 3125 Brisbane QLD 4001

24 July 2008 Application Accepted

Published as AU-B-2006201914

20 November 2008 Standard Patent Sealed

16 July 2009 Assignment Registered

Nektar Therapeutics The patent has been assigned to Novartis AG

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.